2m 2m 2m 2m 2m 2m 2m
ATARA BIOTHER (ATRA)
NASDAQ
$9.64+$0.005 (+0.05%)
Price as of Jun 03, 2026 4:35 PM EDT- $94.7MMarket Cap
- 15.61%1-Year Change
- BiotechnologyIndustry
ATARA BIOTHER (ATRA)
$9.64+$0.005 (+0.05%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 120.8M -6.33% | 128.9M +1,404.02% | 8.6M N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 120.8M -6.33% | 128.9M +1,404.02% | 8.6M N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -37.4M -75.28% | -151.5M -32.61% | -224.8M -17.52% | -272.5M -3.36% | |
Depreciation and Amortization Expense | 2.1M -58.11% | 5.1M +4.60% | 4.8M -14.58% | 5.7M -39.51% | |
Total Operating Expenses | 84.9M -60.02% | 212.4M -25.37% | 284.6M -17.29% | 344.1M -4.63% | |
Operating Profit | 35.9M +142.98% | -83.4M -69.77% | -276.0M -1.61% | -280.5M -17.61% | |
Interest Income | 683,000 -67.63% | 2.1M -61.11% | 5.4M N/A | N/A N/A | |
Interest Expense | -3.8M -17.83% | -4.6M -12.68% | -5.3M N/A | N/A N/A | |
Interest Income and Expense and Net | -3.1M +24.11% | -2.5M -1,876.60% | 141,000 N/A | 0 N/A | |
Total Nonoperating Income and Expense | -34,000 -106.44% | 528,000 +314.63% | -246,000 -112.39% | 2.0M +441.14% | |
Income before Taxes | 32.7M +138.31% | -85.4M -69.06% | -276.1M +20.95% | -228.3M -32.87% | |
Income Taxes | 31,000 +358.33% | -12,000 -180.00% | 15,000 +25.00% | 12,000 -73.91% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 32.7M +138.28% | -85.4M -69.07% | -276.1M +20.95% | -228.3M -32.88% | |
Net Income from Continuing Operations Applicable to Common | 32.7M +138.31% | -85.4M -69.06% | -276.1M +20.95% | -228.3M -32.87% | |
Basic EPS and Net Income | 2.61 +122.87% | -11.41 +337.16% | -2.61 +16.52% | -2.24 -38.29% | |
Diluted EPS and Net Income | 2.57 +122.52% | -11.41 +337.16% | -2.61 +16.52% | -2.24 -38.29% | |
Basic Weighted Average Shares | 12.5M +67.52% | 7.5M -92.93% | 105.9M +3.85% | 102.0M +8.88% | |
Diluted Weighted Average Shares | 12.7M +69.85% | 7.5M -92.93% | 105.9M +3.85% | 102.0M +8.88% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 8.5M -66.11% | 25.0M -3.14% | 25.8M -72.20% | 92.9M -12.39% | |
Short-Term Investments | 0 -100.00% | 17.5M -32.52% | 25.9M -82.73% | 149.9M -43.44% | |
Cash and Cash Equivalents and Short-Term Investments | 8.5M -80.04% | 42.5M -17.84% | 51.7M -78.70% | 242.8M -34.56% | |
Total Current Assets | 12.2M -81.18% | 64.9M -36.30% | 101.9M -65.48% | 295.1M -23.28% | |
Accumulated Depreciation | 213,000 -98.77% | 17.3M +9.06% | 15.9M +27.75% | 12.4M -56.78% | |
Property and Plant and Equipment and Net | 73,000 -94.36% | 1.3M -66.44% | 3.9M -38.79% | 6.3M -88.29% | |
Total Long-Term Assets | 886,000 -71.45% | 3.1M -35.94% | 4.8M -30.98% | 7.0M +196.49% | |
Total Assets | 20.2M -81.45% | 109.1M -34.08% | 165.5M -56.03% | 376.4M -19.59% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 14.9M -88.91% | 134.6M -5.38% | 142.2M +80.22% | 78.9M -25.40% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 1.8M -45.09% | 3.3M -29.41% | 4.6M -16.77% | 5.6M +270.69% | |
Total Liabilities | 58.7M -71.54% | 206.4M -22.04% | 264.7M +5.99% | 249.8M +32.50% | |
Retained Earnings | -2.0B -1.59% | -2.1B +4.34% | -2.0B +16.31% | -1.7B +15.59% | |
Total Stockholders Equity | -38.5M -60.42% | -97.3M -1.96% | -99.2M -178.36% | 126.6M -54.71% | |
Total Shares Outstanding | 7.3M +25.00% | 5.9M -94.50% | 106.4M +10.97% | 95.9M +4.64% | |
Cash Flow | |||||
Cash from Operating Activities | -50.9M -25.87% | -68.7M -64.39% | -193.0M -28.64% | -270.4M +22.63% | |
Capital Expenditures | 0 -100.00% | 246,000 -79.89% | 1.2M -70.83% | 4.2M -60.37% | |
Cash from Investing Activities | 18.1M +110.44% | 8.6M -93.04% | 123.9M -38.97% | 203.0M +811.83% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 16.1M -72.85% | 59.3M +2,849.35% | 2.0M -96.21% | 53.1M -48.93% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | 29.69% +145.89% | -64.71% -97.99% | -3,219.48% N/A | N/A N/A | |
Return on Assets | 50.55% +181.27% | -62.20% -38.96% | -101.91% +88.49% | -54.06% -16.06% | |
Return on Equity | -48.15% -155.39% | 86.92% +104.31% | -2,014.86% +1,692.68% | -112.39% +22.58% | |
Revenue Growth | -6.33% -100.45% | 1,404.02% N/A | N/A N/A | N/A N/A | |
Current Ratio | 0.82 +69.72% | 0.48 -32.67% | 0.72 -80.85% | 3.74 +2.84% | |
Cash Ratio | 0.57 +205.59% | 0.19 +2.37% | 0.18 -84.57% | 1.18 +17.44% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow